Oral magnesium supplementation does not affect insulin sensitivity in people with insulin-treated type 2 diabetes and a low serum magnesium: a randomised controlled trial
Conclusions/interpretationDespite an albeit modest increase in serum magnesium concentration, oral magnesium supplementation does not improve insulin sensitivity in people with insulin-treated type 2 diabetes and low magnesium levels.Trial registrationEudraCT number 2021-001243-27.FundingThis study was supported by a grant from the Dutch Diabetes Research Foundation (2017 –81–014).Graphical Abstract
Source: Diabetologia - Category: Endocrinology Source Type: research
More News: Advertising | Cholesterol | Diabetes | Diabetes Type 2 | Endocrinology | Grants | Insulin | Magnesium | Netherlands Health | Study | Women